• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Innexus Biotechnology Inc


Ticker Delisted

Snapshot for Innexus Biotechnology Inc (IHE)

Open: - Day's Range: - Volume: 0
Previous Close: - 52wk Range: - 1-Yr Rtn: -

Stock Chart for IHE

No chart data available.
  • IHE:GR
  • 1M
  • 1Y
Interactive IHE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IHE

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 0.00
Shares Outstanding (M) 0.00
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IHE

No data available

Company Profile & Key Executives for IHE

InNexus Biotechnology Inc. is developing a new generation of monoclonal antibodies termed SuperAntibodies (SAT). The Company is exploiting SAT to generate second generation diagnostic and therapeutic antibodies. InNexus is focused on marketing the SAT to the pharmaceutical community for the purpose of entering into licensing agreements.

Jeff MorhetChairman/CEOAngela GiannoccaroChief Financial Officer
Jur StrobosChief Medical OfficerThomas KindtChief Scientific Officer
More Company Profile & Key Executives for IHE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil